ImmunityBio Inc.

NASDAQ: IBRX · Real-Time Price · USD
2.49
-0.02 (-0.80%)
At close: May 14, 2025, 3:59 PM
2.50
0.40%
Pre-market: May 15, 2025, 05:27 AM EDT

ImmunityBio Revenue

ImmunityBio reported an annual revenue of $14.74M, reflecting a 2270.58% growth. For the quarter ending March 31, 2025, ImmunityBio generated $16.52M in revenue.
Revenue (ttm)
$14.74M
Revenue Growth
2270.58%
Price / Sales Ratio
121.07
Revenue / Employee
$21.68K
Employees
680
Market Cap
2.2B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.